WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by the environmental non-profit ...

The FA Cup has always been a stage for surprises, but few predicted the stunning upset that unfolded in the first round this year as Wuxi's Wu Gou triumphed over Shanghai Zetian with a resounding 2-0 ...

With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. Still, geopolitical uncertainties under the second Trump administration loom large over ...

Shares in WuXi AppTec rose sharply after the Chinese biotechnology company proposed a special dividend and share buyback following weaker annual results. The company's shares in Hong Kong climbed as ...

Chinese stocks ended higher, supported by home appliance and pharma stocks. Despite the impact of China's ...

The opening performance of Wuxi Wu Gou resembled a tiger descending the mountain, showcasing their aggressive approach and solid defense. Shanghai Ze Tian fought valiantly, but Wu Gou's backline was ...

WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, ...

Its Shanghai-listed stock was recently 9.7% higher ... is expected to be paid by June 30. WuXi AppTec also said it plans to repurchase about 1 billion yuan, equivalent to $138.3 million, of ...